The global MRI compatible patient monitoring systems market holds a forecasted share of US$ 3,851.4 million in 2022 and is likely to surpass US$ 5,958.6 million by 2032, moving ahead with a CAGR of 4% during the forecast period.
Magnetic Resonance Imaging (MRI) is a valuable diagnostic tool for identifying diseases related to spine lesions, tumors, and strokes affecting the blood vessels and the brain. The prevalence of these diseases is driving the growth of the MRI compatible patient monitoring systems market.
| Report Attribute | Details |
|---|---|
| MRI Compatible Patient Monitoring Systems Market Value (2022) | US$ 3,851.4 million |
| MRI Compatible Patient Monitoring Systems Market Anticipated Forecast Value (2032) | US$ 5,958.6 million |
| MRI Compatible Patient Monitoring Systems Market Projected Growth Rate (2022 to 2032) | 4% |
In 2020, the International Agency for Research on Cancer reported 19,292,789 new cancer cases worldwide. MRI machines are expected to be widely adopted due to the growing demand for quick and effective diagnostic procedures. Various countries are installing these MRI machines. According to the OECD, 34.54 MRI units were installed in the USA in 2020. Artificial intelligence may also have a positive impact on the market in the future.
MRI compatible patient monitoring systems are technologically modified and equipped with safety features, such as alarms or other operator alerts that are meant to trigger in the event of a problem, thus shaping key trends and opportunities in the market for MRI compatible patient monitoring systems.
There has been a tremendous amount of advancement in MRI technology over recent years, especially in the software field. It has also been driven by advancements in diagnostic techniques such as open MRI, visualization software, and superconducting magnets. Furthermore, the development of cardiac pacemaker-compatible MRI systems is expected to propel market growth in the cardiology segment.
Further, various paramagnetic contrast agents, such as gadolinium-DTPA, can be injected intravenously to provide sharp, precise, and accurate images within a short period. As a result of these technological advancements in MRI, market growth is expected to accelerate during the forecast period.
MRI manufacturers have continued to adopt newer technology and develop artificial intelligence (AI)-based solutions to increase the market growth. Radiologists used this to understand chronic diseases and residual symptoms more effectively and efficiently. MRI is expected to play a key role in patient monitoring as clinicians seek to find out what is causing long-term chronic disease symptoms
Several recent advancements, such as diffusion and diffusion tensor imaging with tractography, neuroimaging such as MR spectroscopy, perfusion imaging, and functional imaging utilizing the bold technique, are expected to boost market growth during the forecast period. It is also expected that the market will grow as intraoperative MRI grows in popularity and is applied in several applications, including neurosurgery.
There are several advantages associated with MRI systems, but the costs associated with purchasing and installing such machines are quite high, which in turn affects the growth of the market, particularly in developing regions. Low- to medium-strength MRI machines cost more than one million dollars on average. Furthermore, helium gas is depleting at an alarming rate, resulting in increased wait time and a reduction in productivity.
The growth of the market is also negatively impacted by the delayed approval of products and frequent recalls of products primarily because of stringent regulatory frameworks.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Drivers:
Restraints:
It is anticipated that mixed results with MRI screening may hinder the growth of the global MRI compatible patient monitoring systems market. For instance, in November 2019, researchers at Utrecht University Medical Center, The Netherlands, published a study finding that the rate of interval cancers was reduced by half in patients with dense breast tissue when mammography was complemented with magnetic resonance imaging (MRI). However, there was a significant rate of recall for additional imaging.
Some factors will limit the growth of the MRI compatible patient monitoring system market in the future. These factors include the risk associated with MRI scans, the strict regulatory requirements for approving devices, and the high cost of devices. An MRI examination takes a considerable amount of time, and critically ill patients and children are sometimes sedated during the procedure. Medical conditions like respiratory depression and hypoxemia can sometimes result from these scans. According to the Safety Committee of the Society for Magnetic Resonance Imaging, MRI procedures should be physiologically monitored and performed only by a qualified professional.
Opportunities:
There may be ample growth opportunities for players in the MRI compatible patient monitoring system market in several unexplored markets in emerging economies. By monitoring the patient's vital signs, these systems help to avoid any emergencies during the scan. Among the vital signs that can be monitored with these systems are electrocardiography, pulse oximetry, and invasive blood pressure (IBP).
Further, these systems can be used to monitor pediatric patients, patients who are mentally ill, and critically ill patients, as well as patients with compromised physiologic functions. In this way, the players may be able to expand their product portfolios as the number of applications for these systems grows.
With a market share of 35.2% in 2022, North America is expected to dominate the MRI compatible patient monitoring systems market. As a result of an increasing geriatric population, lifestyle-associated diseases, and the adoption of technologically advanced devices, North America may dominate the global MRI compatible patient monitoring system market in the years to come. As medical infrastructure and reimbursement facilities develop along with technological advancements, the North American MRI compatible patient monitoring systems market is expected to register significant growth over the forecast period.
The North American MRI compatible patient monitoring system market size is expected to grow due to high healthcare spending and rising chronic disease prevalence.
Europe is expected to contribute modestly to the market, as well as a healthy growth rate, with MRI compatible patient monitoring systems occupying 31.9% of the market in 2022.
With an increase in elderly people and growing awareness about MRI compatible patient monitoring systems, the European MRI compatible patient monitoring systems market is expected to grow. In fact, 47% of the four million deaths there each year are caused by cardiovascular diseases, according to the European Society of Cardiology, a non-profit medical organization.
Principal Consultant
In developing economies, favorable government policies for start-up companies like medical device manufacturers and new manufacturing facilities support capacity expansion by leading manufacturers.
The Butterfly iQ, created by Butterfly Network, is a portable, handheld ultrasound imaging device with a built-in battery and wireless charging that can perform scans for more than two hours. Butterfly Network was founded in 2011.
Additionally, it enables the organization, searching, and access of cloud-based studies via mobile or web. Several prominent investors have contributed to the raising of US$ 350 million raised by this start-up, triggering new trends in the market for MRI-compatible patient monitoring systems.
MRI Compatible Patient Monitoring Systems Market: Key Contracts/ Agreements/ Acquisitions/ Recent Developments
To increase the adoption and usage of MRI machines in the field of medical imaging, key players are developing machines with high field strength. Aside from expansions of their regional and service portfolios, these players are also undertaking mergers and acquisitions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 4% from 2022 to 2032 |
| Base Year for Estimation | 2022 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The MRI compatible patient monitoring systems market's growth potential can be valued at US$ 5958.6 Million by 2032.
The market size of the global MRI Compatible Patient Monitoring Systems Market is projected to grow by US$ 3851.4 Million in 2022.
The MRI compatible patient monitoring systems market is expected to grow at a CAGR of 4% from 2022 to 2032.
North America is expected to hold the highest share in the global MRI compatible patient monitoring systems market.
1. Executive Summary | MRI Compatible Patient Monitoring Systems Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032
5.3.1. Magnetic Devices
5.3.2. Non-magnetic Devices
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Modality Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Modality Type, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Modality Type, 2022 to 2032
6.3.1. Portable
6.3.2. Non-portable
6.4. Y-o-Y Growth Trend Analysis By Modality Type, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Modality Type, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2021
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032
7.3.1. Blood Glucose Monitoring
7.3.2. EEG and ECG Monitoring
7.3.3. Capnography Monitoring
7.3.4. Spirometer Monitoring
7.3.5. Sleep Apnea Monitoring
7.3.6. Pulse Oximeter Monitoring
7.3.7. Fetal Doppler Monitoring
7.3.8. Multi-parameter Monitoring
7.3.9. Weight Monitoring
7.3.10. Temperature Monitoring
7.3.11. Other Applications
7.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021
7.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Diagnostics Centers
8.3.4. Emergency Medical Services
8.3.5. Others
8.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
8.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa(MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Product Type
10.2.3. By Modality Type
10.2.4. By Application
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Modality Type
10.3.4. By Application
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product Type
11.2.3. By Modality Type
11.2.4. By Application
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Modality Type
11.3.4. By Application
11.3.5. By End User
11.4. Key Takeaways
12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. United Kingdom
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Product Type
12.2.3. By Modality Type
12.2.4. By Application
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Modality Type
12.3.4. By Application
12.3.5. By End User
12.4. Key Takeaways
13. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.1.4. India
13.2.1.5. Malaysia
13.2.1.6. Singapore
13.2.1.7. Australia
13.2.1.8. New Zealand
13.2.1.9. Rest of Asia Pacific
13.2.2. By Product Type
13.2.3. By Modality Type
13.2.4. By Application
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Modality Type
13.3.4. By Application
13.3.5. By End User
13.4. Key Takeaways
14. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of Middle East and Africa(MEA)
14.2.2. By Product Type
14.2.3. By Modality Type
14.2.4. By Application
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Modality Type
14.3.4. By Application
14.3.5. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Product Type
15.1.2.2. By Modality Type
15.1.2.3. By Application
15.1.2.4. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Product Type
15.2.2.2. By Modality Type
15.2.2.3. By Application
15.2.2.4. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Product Type
15.3.2.2. By Modality Type
15.3.2.3. By Application
15.3.2.4. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Product Type
15.4.2.2. By Modality Type
15.4.2.3. By Application
15.4.2.4. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Product Type
15.5.2.2. By Modality Type
15.5.2.3. By Application
15.5.2.4. By End User
15.6. United Kingdom
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Product Type
15.6.2.2. By Modality Type
15.6.2.3. By Application
15.6.2.4. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Product Type
15.7.2.2. By Modality Type
15.7.2.3. By Application
15.7.2.4. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Product Type
15.8.2.2. By Modality Type
15.8.2.3. By Application
15.8.2.4. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Product Type
15.9.2.2. By Modality Type
15.9.2.3. By Application
15.9.2.4. By End User
15.10. China
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Product Type
15.10.2.2. By Modality Type
15.10.2.3. By Application
15.10.2.4. By End User
15.11. Japan
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Product Type
15.11.2.2. By Modality Type
15.11.2.3. By Application
15.11.2.4. By End User
15.12. South Korea
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Product Type
15.12.2.2. By Modality Type
15.12.2.3. By Application
15.12.2.4. By End User
15.13. Malaysia
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Product Type
15.13.2.2. By Modality Type
15.13.2.3. By Application
15.13.2.4. By End User
15.14. Singapore
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Product Type
15.14.2.2. By Modality Type
15.14.2.3. By Application
15.14.2.4. By End User
15.15. Australia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Product Type
15.15.2.2. By Modality Type
15.15.2.3. By Application
15.15.2.4. By End User
15.16. New Zealand
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Product Type
15.16.2.2. By Modality Type
15.16.2.3. By Application
15.16.2.4. By End User
15.17. GCC Countries
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Product Type
15.17.2.2. By Modality Type
15.17.2.3. By Application
15.17.2.4. By End User
15.18. South Africa
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Product Type
15.18.2.2. By Modality Type
15.18.2.3. By Application
15.18.2.4. By End User
15.19. Israel
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Product Type
15.19.2.2. By Modality Type
15.19.2.3. By Application
15.19.2.4. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product Type
16.3.3. By Modality Type
16.3.4. By Application
16.3.5. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. iRadimed Corporation
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Fresenius Kabi AG
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. B. Braun Melsungen AG
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Becton, Dickinson Company
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Smiths Medical
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Baxter International Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Arcomed AG
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Deltex Medical Group Plc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Philips Medical Systems
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. GE Healthcare
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. Draeger Medical, Inc.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.12. Schwarzer Cardiotek GmbH
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.13. Tensys Medical, Inc.
17.1.13.1. Overview
17.1.13.2. Product Portfolio
17.1.13.3. Profitability by Market Segments
17.1.13.4. Sales Footprint
17.1.13.5. Strategy Overview
17.1.13.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
MRI Compatible Patient Monitoring Systems Market
